NCT03952819View on ClinicalTrials.gov

The Effects of Hemodialysis on Serum Sclerostin Levels

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

September 14, 2017

Primary Completion Date

November 15, 2018

Study Completion Date

December 15, 2018

Conditions
Diabetes MellitusRenal FailureHemodialysis Access Failure
Interventions
DIAGNOSTIC_TEST

serum sclerostin

blood samples obtained

Trial Locations (1)

14100

Bolu Abant Izzet Baysal University, Bolu

All Listed Sponsors
lead

Abant Izzet Baysal University

OTHER

NCT03952819 - The Effects of Hemodialysis on Serum Sclerostin Levels | Biotech Hunter | Biotech Hunter